MREO Stock Analysis: Buy, Sell, or Hold?
MREO - Mereo BioPharma Group plc American Depositary Shares
$0.29
0.00 (-0.99%)
âŧ
5d:
-8.94%
30d:
-0.21%
90d:
+6.73%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When MREO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MREO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MREO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MREO is currently trading at $0.29, which is considered slightly low relative to its 30-day fair value range of $0.29 to $0.32.
Technical Outlook: Technically, MREO is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.37.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.02 (+594.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MREO is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.37.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.02 (+594.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.29 -
$0.32
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: Trading 594.2% below Wall St target ($2.02)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.29 -
$0.32
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.37
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.79
Wall Street Target
$2.02
(+594.2%)
Share & Embed Analysis
Last updated: August 23, 2026 8:41 PM ET
Data refreshes hourly during market hours. Next update: 9:41 PM
Data refreshes hourly during market hours. Next update: 9:41 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MREO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1173 | 43 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 39 SELL |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
